MyFinsight
Home
Blog
About
Back
Cash Flow
Hepion Pharmaceuticals, Inc. (CTRVP)
Hepion Pharmaceuticals, Inc. (CTRVP)
source: myfinsight.com
Proceeds from the
issuance of common stock...
$700,000
(-92.22%↓ Y/Y)
Net cash provided by
financing activities
$420,000
(-91.83%↓ Y/Y)
Canceled cashflow
$280,000
Net increase
(decrease) in cash
-$973,955
(-138.68%↓ Y/Y)
Canceled cashflow
$420,000
Change in fair value of
derivative financial...
$42,989
(-98.95%↓ Y/Y)
Accounts payable and
accrued expenses
$7,187
(131.67%↑ Y/Y)
something is missing
-$250,000
Equity issuance costs
$30,000
(-96.26%↓ Y/Y)
Net cash used in
operating activities
-$1,393,955
(44.08%↑ Y/Y)
Canceled cashflow
$50,176
Net loss
-$1,248,237
(82.54%↑ Y/Y)
Prepaid expenses and
other assets
$195,894
(228.51%↑ Y/Y)
Back